Clinical Trials Directory

Trials / Unknown

UnknownNCT03346317

Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent Combined With Estrogen or Dried Biological Amnion Graft for the Therapy of Uterine Adhesion

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Beijing Obstetrics and Gynecology Hospital · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the treatment of intrauterine adhesions is hysteroscopic intrauterine adhesions. The recurrence of intrauterine adhesions is a major challenge in clinical practice. It has been reported that dried biological aminion graft was used to prevent adhesion after the operation of intrauterine adhesions. Estrogen is also used for postoperative prevention of intrauterine adhesions. Intrauterine balloon can reduce the recurrence of adhesions after operation. Does the combination of balloon with amniotic products or estrogen can improve clinical outcomes? Therefore, this study was conducted.

Detailed description

Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double (participant and outcomes Assessor) Primary Purpose: Prevention

Conditions

Interventions

TypeNameDescription
DEVICEdisposable balloon uterine stentThe disposable balloon uterine stent is heart-shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to Foley catheter.
PROCEDUREdried biological amnion graftUterine application of amnion membrane following hysteroscopic adhesiolysis. Other Name: Human amnion membrane
DRUGestradiol valerate tablets+dydrogesterone tabletsoral estradiol valerate tablets+dydrogesterone tablets

Timeline

Start date
2017-11-16
Primary completion
2018-05-16
Completion
2018-05-20
First posted
2017-11-17
Last updated
2017-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03346317. Inclusion in this directory is not an endorsement.